Bioaccessibility of arsenic from contaminated soils and alteration of the gut microbiome in an in vitro gastrointestinal model
- PMID: 35835276
- PMCID: PMC9667710
- DOI: 10.1016/j.envpol.2022.119753
Bioaccessibility of arsenic from contaminated soils and alteration of the gut microbiome in an in vitro gastrointestinal model
Abstract
Arsenic exposure has been reported to alter the gut microbiome in mice. Activity of the gut microbiome derived from fecal microbiota has been found to affect arsenic bioaccessibility in an in vitro gastrointestinal (GI) model. Only a few studies have explored the relation between arsenic exposure and changes in the composition of the gut microbiome and in arsenic bioaccessibility. Here, we used simulated GI model system (GIMS) containing a stomach, small intestine, colon phases and microorganisms obtained from mouse feces (GIMS-F) and cecal contents (GIMS-C) to assess whether exposure to arsenic-contaminated soils affect the gut microbiome and whether composition of the gut microbiome affects arsenic bioaccessibility. Soils contaminated with arsenic did not alter gut microbiome composition in GIMS-F colon phase. In contrast, arsenic exposure resulted in the decline of bacteria in GIMS-C, including members of Clostridiaceae, Rikenellaceae, and Parabacteroides due to greater diversity and variability in microbial sensitivity to arsenic exposure. Arsenic bioaccessibility was greatest in the acidic stomach phase of GIMS (pH 1.5-1.7); except for GIMS-C colon phase exposed to mining-impacted soil in which greater levels of arsenic solubilized likely due to microbiome effects. Physicochemical properties of different test soils likely influenced variability in arsenic bioaccessibility (GIMS-F bioaccessibility range: 8-37%, GIMS-C bioaccessibility range: 2-18%) observed in this study.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Predictive capabilities of in vitro colon bioaccessibility for estimating in vivo relative bioavailability of arsenic from contaminated soils: Arsenic speciation and gut microbiota considerations.Sci Total Environ. 2022 Apr 20;818:151804. doi: 10.1016/j.scitotenv.2021.151804. Epub 2021 Nov 20. Sci Total Environ. 2022. PMID: 34808186
-
In vitro model insights into the role of human gut microbiota on arsenic bioaccessibility and its speciation in soils.Environ Pollut. 2020 Aug;263(Pt A):114580. doi: 10.1016/j.envpol.2020.114580. Epub 2020 Apr 16. Environ Pollut. 2020. PMID: 33618458
-
Variability of arsenic bioaccessibility and metabolism in soils by human gut microbiota using different in vitro methods combined with SHIME.Sci Total Environ. 2016 Oct 1;566-567:1670-1677. doi: 10.1016/j.scitotenv.2016.06.071. Epub 2016 Jun 16. Sci Total Environ. 2016. PMID: 27320743
-
Interconnected soil iron and arsenic speciation effects on arsenic bioaccessibility and bioavailability: a scoping review.J Toxicol Environ Health B Crit Rev. 2022 Jan 2;25(1):1-22. doi: 10.1080/10937404.2021.1996499. Epub 2021 Oct 27. J Toxicol Environ Health B Crit Rev. 2022. PMID: 34706629 Free PMC article.
-
Literature review and meta-analysis of gastric and intestinal bioaccessibility for nine inorganic elements in soils and soil-like media for use in human health risk assessment.Int J Hyg Environ Health. 2022 Mar;240:113929. doi: 10.1016/j.ijheh.2022.113929. Epub 2022 Jan 29. Int J Hyg Environ Health. 2022. PMID: 35092898 Review.
Cited by
-
Trace elements in pancreatic cancer.Cancer Med. 2024 Jul;13(14):e7454. doi: 10.1002/cam4.7454. Cancer Med. 2024. PMID: 39015024 Free PMC article. Review.
-
Key characteristics of carcinogens meet hallmarks for prevention-cutting the Gordian knot.Front Oncol. 2024 Sep 10;14:1420687. doi: 10.3389/fonc.2024.1420687. eCollection 2024. Front Oncol. 2024. PMID: 39435286 Free PMC article.
-
Air Pollution, Oxidative Stress, and the Risk of Development of Type 1 Diabetes.Antioxidants (Basel). 2022 Sep 27;11(10):1908. doi: 10.3390/antiox11101908. Antioxidants (Basel). 2022. PMID: 36290631 Free PMC article. Review.
-
Arsenic-Containing Medicine Treatment Disturbed the Human Intestinal Microbial Flora.Toxics. 2023 May 15;11(5):458. doi: 10.3390/toxics11050458. Toxics. 2023. PMID: 37235272 Free PMC article.
-
Human Health Risk and Bioaccessibility of Arsenic in Wadis and Marine Sediments in a Coastal Lagoon (Mar Menor, Spain).Toxics. 2025 Jul 30;13(8):647. doi: 10.3390/toxics13080647. Toxics. 2025. PMID: 40863923 Free PMC article.
References
-
- Agency for Toxic Substances and Disease Registry, 2017. ATSDR’s Substance Priority List, 2018 12/04/2018]; Available from: https://www.atsdr.cdc.gov/spl/#2017spl.
-
- Alava P, et al., 2013. Arsenic bioaccessibility upon gastrointestinal digestion is highly determined by its speciation and lipid-bile salt interactions. J. Environ. Sci. Health - Part A Toxic/Hazard. Subst. Environ. Eng 48 (6), 656–665. - PubMed
-
- Alava P, et al., 2015. Westernized diets lower arsenic gastrointestinal bioaccessibility but increase microbial arsenic speciation changes in the colon. Chemosphere 119, 757–762. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical